Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.03 from other evidence | 0.00 |
| cell type Human Protein Atlas | group enriched outside the brain (oocytes) | 0.10 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 2 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 6530
Sealed predictions
- MIXL1 in dopamine neurons, braak+0.63 (p 0.068) → -0.27 (p 0.485)receipt 6537
Swarm cases
receipt 6537: MIXL1 in dopamine neurons, braak
- power
- full sample +0.39 (p 0.107, n 18), 95% CI -0.09 to +0.73. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.47 (p 0.049, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.41 (p 0.095, n 18). could be the mix.
- skeptic
- leave-one-out range +0.32 to +0.50, sign flips 0; without severely affected donors +0.39 (p 0.107, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MIXL1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts